 |
 |
| Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
| JR6-L2832 |
 |
1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-, methyl ester |
96%
|
|
Delete |
| AS-4506 |
 |
2-Bromoquinoline |
98%
|
|
Delete |
| AS-7458 |
 |
2-Nitroimidazole |
98%
|
|
Delete |
| JR6-L7586 |
 |
2-Pyridinecarbonitrile, 6-[(2R)-2-aminopropyl]- |
96%
|
|
Delete |
| JR6-L7570 |
 |
2-Pyridineethanamine, 4-amino-a-methyl-, (aR)- |
96%
|
|
Delete |
| JR6-L7572 |
 |
2-Pyridineethanamine, 5-amino-a-methyl-, (aR)- |
96%
|
|
Delete |
| JR6-L6060 |
 |
3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine, 3-[(3-nitrophenyl)methyl]-7-phenyl- |
96%
|
|
Delete |
| AS-2881 |
 |
4-Bromo-2-fluorobiphenyl |
98%
|
|
Delete |
| JR6-L7145 |
 |
ACETYLPYRAZINE |
96%
|
|
Delete |
| JR6-L6133 |
 |
Benzamide, N-[4-[[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-4-methoxy- |
96%
|
|
Delete |
| JR6-L2437 |
 |
Benzenemethanol, 4-ethoxy-a-(trifluoromethyl)- |
96%
|
$480/1g, $780/2g, $1280/5g, $3980/25g |
Delete |
| JR6-L2005 |
 |
Benzo[2,1-b:3,4-b']dithiophene-4,5-dione, 2,7-dibromo |
96%
|
$298/1g, $880/5g, $2980/25g, $9800/100g, bulky available |
Delete |
| JR6-L2007 |
 |
Benzo[2,1-b:3,4-b']dithiophene-4,5-dione, 2,7-diethynyl- |
96%
|
|
Delete |
| JR6-L1611 |
 |
Borate(1-), [2-[(hydroxy-O)methyl]-2-methyl-1,3-propanediolato(3-)-O1,O3]phenyl-, lithium (1:1), (T-4)- |
96%
|
|
Delete |
| JR6-L2019 |
 |
Butanoic acid, 2-hydroxy-2-methyl-, (2S)- |
96%
|
$780/1g, $2480/5g, $6980/25g |
Delete |
| JR6-L2011 |
 |
Dithieno[3,2-a:2',3'-c]phenazine, 2,5-dibromo- |
96%
|
|
Delete |
| JR8-N1056 |
 |
Gypenoside XVII |
98%
|
$800/20mg |
Delete |
| JR6-L6034 |
 |
L-Phenylalanine, 4-[2-amino-6-[(1,2-diphenylethyl)amino]-4-pyrimidinyl]- |
96%
|
$980/10mg, $5980/100mg, 500mg, 1g, 5g |
Delete |
| AS-3125 |
 |
N,N-Dibenzylethanolamine |
98%
|
|
Delete |
| JR6-L3479 |
 |
Oxirane, 2-(phenylmethyl)-, (2S)- |
96%
|
|
Delete |
| JR8-N0675 |
 |
Solaneso |
98%
|
|
Delete |
| JR8-N1050 |
 |
Tauroursodeoxycholic acid |
98%
|
$500/20mg |
Delete |
|
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |